These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 36232758)

  • 1. Measurement of Hepatic CYP3A4 and 2D6 Activity Using Radioiodine-Labeled
    Mizutani A; Kobayashi M; Aibe R; Muranaka Y; Nishi K; Kitamura M; Suzuki C; Nishii R; Shikano N; Magata Y; Ishida Y; Kunishima M; Kawai K
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Venlafaxine metabolism as a marker of cytochrome P450 enzyme 2D6 metabolizer status.
    Nichols AI; Lobello K; Guico-Pabia CJ; Paul J; Preskorn SH
    J Clin Psychopharmacol; 2009 Aug; 29(4):383-6. PubMed ID: 19593180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of CYP2D6 genotype on the disposition of the enantiomers of venlafaxine and its major metabolites in postmortem femoral blood.
    Kingbäck M; Karlsson L; Zackrisson AL; Carlsson B; Josefsson M; Bengtsson F; Ahlner J; Kugelberg FC
    Forensic Sci Int; 2012 Jan; 214(1-3):124-34. PubMed ID: 21840145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influences of CYP2D6 genotypes and drug interactions on the pharmacokinetics of venlafaxine: exploring predictive biomarkers for treatment outcomes.
    Jiang F; Kim HD; Na HS; Lee SY; Seo DW; Choi JY; Ha JH; Shin HJ; Kim YH; Chung MW
    Psychopharmacology (Berl); 2015 Jun; 232(11):1899-909. PubMed ID: 25510856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of CYP2D6 Genotypes on Venlafaxine Metabolism in Japanese Psychiatric Patients With Depression.
    Komahashi-Sasaki H; Yasui-Furukori N; Sasaki T; Shinozaki M; Hayashi Y; Kato K; Inoue Y; Tsuchimine S; Watanabe T; Sugawara N; Shimoda K
    Ther Drug Monit; 2021 Oct; 43(5):681-687. PubMed ID: 33306568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin and Norepinephrine Reuptake Inhibitors.
    Shelton RC
    Handb Exp Pharmacol; 2019; 250():145-180. PubMed ID: 30838456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the pharmacokinetic interaction between ticagrelor and venlafaxine, a cytochrome P-450 2D6 substrate, in healthy subjects.
    Teng R; Kujacic M; Hsia J
    Clin Ther; 2014 Sep; 36(9):1217-25. PubMed ID: 25069798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nifedipine Does Not Alter the Pharmacokinetics of Venlafaxine Enantiomers in Healthy Subjects Phenotyped for CYP2D6, CYP2C19, and CYP3A.
    Tozatto E; Benzi JRL; Rocha A; Coelho EB; Lanchote VL
    J Clin Pharmacol; 2021 Mar; 61(3):319-327. PubMed ID: 32974907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of Zuojin Pill on the Metabolism of Venlafaxine in Vitro and in Rats and Associated Herb-Drug Interaction.
    Li Y; Li J; Yan D; Wang Q; Jin J; Tan B; Qiu F
    Drug Metab Dispos; 2020 Oct; 48(10):1044-1052. PubMed ID: 32561594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Marsdenia tenacissima extract inhibits gefitinib metabolism in vitro by interfering with human hepatic CYP3A4 and CYP2D6 enzymes.
    Han SY; Zhao HY; Zhou N; Zhou F; Li PP
    J Ethnopharmacol; 2014; 151(1):210-7. PubMed ID: 24157377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risperidone and Venlafaxine Metabolic Ratios Strongly Predict a CYP2D6 Poor Metabolizing Genotype.
    Mannheimer B; Haslemo T; Lindh JD; Eliasson E; Molden E
    Ther Drug Monit; 2016 Feb; 38(1):127-34. PubMed ID: 26418700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CYP2D6 polymorphism and clinical effect of the antidepressant venlafaxine.
    Shams ME; Arneth B; Hiemke C; Dragicevic A; Müller MJ; Kaiser R; Lackner K; Härtter S
    J Clin Pharm Ther; 2006 Oct; 31(5):493-502. PubMed ID: 16958828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Influence of Combined CYP2D6 and CYP2C19 Genotypes on Venlafaxine and O-Desmethylvenlafaxine Concentrations in a Large Patient Cohort.
    Kringen MK; Bråten LS; Haslemo T; Molden E
    J Clin Psychopharmacol; 2020; 40(2):137-144. PubMed ID: 32134850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytochrome P450 expression and regulation in CYP3A4/CYP2D6 double transgenic humanized mice.
    Felmlee MA; Lon HK; Gonzalez FJ; Yu AM
    Drug Metab Dispos; 2008 Feb; 36(2):435-41. PubMed ID: 18048490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism of the active metabolite of quetiapine, N-desalkylquetiapine in vitro.
    Bakken GV; Molden E; Knutsen K; Lunder N; Hermann M
    Drug Metab Dispos; 2012 Sep; 40(9):1778-84. PubMed ID: 22688609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytochrome b5 is a major determinant of human cytochrome P450 CYP2D6 and CYP3A4 activity in vivo.
    Henderson CJ; McLaughlin LA; Scheer N; Stanley LA; Wolf CR
    Mol Pharmacol; 2015 Apr; 87(4):733-9. PubMed ID: 25657337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversible cardiac dysfunction after venlafaxine overdose and possible influence of genotype and metabolism.
    Castanares-Zapatero D; Gillard N; Capron A; Haufroid V; Hantson P
    Forensic Sci Int; 2016 Sep; 266():e48-e51. PubMed ID: 27328779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Trigonella foenum-graecum L. on Metabolic Activity of CYP2D6 and CYP3A4.
    Al-Jenoobi FI; Al-Thukair AA; Alam MA; Abbas FA; Al-Mohizea AM; Alkharfy KM; Al-Suwayeh SA
    Forsch Komplementmed; 2015; 22(3):180-4. PubMed ID: 26335391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Curcuma longa on CYP2D6- and CYP3A4-mediated metabolism of dextromethorphan in human liver microsomes and healthy human subjects.
    Al-Jenoobi FI; Al-Thukair AA; Alam MA; Abbas FA; Al-Mohizea AM; Alkharfy KM; Al-Suwayeh SA
    Eur J Drug Metab Pharmacokinet; 2015 Mar; 40(1):61-6. PubMed ID: 24510399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum concentrations of venlafaxine and its metabolites O-desmethylvenlafaxine and N-desmethylvenlafaxine in heterozygous carriers of the CYP2D6*3, *4 or *5 allele.
    Hermann M; Hendset M; Fosaas K; Hjerpset M; Refsum H
    Eur J Clin Pharmacol; 2008 May; 64(5):483-7. PubMed ID: 18214456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.